Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$0.0 - $33.97 $0 - $53.6 Million
-1,578,349 Closed
0 $0
Q4 2022

Feb 14, 2023

SELL
$31.15 - $33.39 $1.49 Million - $1.59 Million
-47,756 Reduced 2.94%
1,578,349 $52.4 Million
Q3 2022

Nov 15, 2022

BUY
$30.9 - $33.55 $3,337 - $3,623
108 Added 0.01%
1,626,105 $51.3 Million
Q2 2022

Aug 15, 2022

SELL
$23.75 - $31.69 $729,980 - $974,023
-30,736 Reduced 1.86%
1,625,997 $49.5 Million
Q1 2022

May 16, 2022

SELL
$19.97 - $26.94 $1.59 Million - $2.14 Million
-79,565 Reduced 4.58%
1,656,733 $43 Million
Q4 2021

Feb 14, 2022

SELL
$17.46 - $21.61 $1.7 Million - $2.1 Million
-97,312 Reduced 5.31%
1,736,298 $35.4 Million
Q3 2021

Nov 15, 2021

BUY
$17.35 - $22.5 $653,383 - $847,327
37,659 Added 2.1%
1,833,610 $35.3 Million
Q2 2021

Aug 16, 2021

BUY
$18.01 - $28.32 $2.12 Million - $3.33 Million
117,576 Added 7.01%
1,795,951 $39.8 Million
Q1 2021

May 17, 2021

SELL
$19.76 - $29.89 $5.59 Million - $8.46 Million
-283,030 Reduced 14.43%
1,678,375 $44.1 Million
Q4 2020

Feb 16, 2021

SELL
$15.73 - $21.66 $2.26 Million - $3.12 Million
-143,854 Reduced 6.83%
1,961,405 $36.7 Million
Q3 2020

Nov 10, 2020

BUY
$13.54 - $26.41 $600,580 - $1.17 Million
44,356 Added 2.15%
2,105,259 $35.7 Million
Q2 2020

Aug 14, 2020

BUY
$7.84 - $23.29 $1.77 Million - $5.24 Million
225,168 Added 12.27%
2,060,903 $48 Million
Q1 2020

May 11, 2020

BUY
$5.57 - $11.5 $10.2 Million - $21.1 Million
1,835,735 New
1,835,735 $15.4 Million

Others Institutions Holding VIVO

About MERIDIAN BIOSCIENCE INC


  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.